The store will not work correctly when cookies are disabled.
2-Methyl-N'-(3,4,5-trimethoxybenzylidene)imidazo[1,2-a]pyridine-3-carbohydrazide
ID: ALA3310310
PubChem CID: 118706418
Max Phase: Preclinical
Molecular Formula: C19H20N4O4
Molecular Weight: 368.39
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: COc1cc(/C=N/NC(=O)c2c(C)nc3ccccn23)cc(OC)c1OC
Standard InChI: InChI=1S/C19H20N4O4/c1-12-17(23-8-6-5-7-16(23)21-12)19(24)22-20-11-13-9-14(25-2)18(27-4)15(10-13)26-3/h5-11H,1-4H3,(H,22,24)/b20-11+
Standard InChI Key: YUJKRRMBAXBTAX-RGVLZGJSSA-N
Molfile:
RDKit 2D
27 29 0 0 0 0 0 0 0 0999 V2000
9.9470 -3.2166 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7439 -3.0031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9575 -2.2062 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3741 -1.6228 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5772 -1.8364 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3637 -2.6333 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.5725 -3.9517 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.7577 -3.8226 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6286 -3.0078 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8935 -2.6333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8503 -1.8094 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.1790 -3.0458 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.4646 -2.6333 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.7501 -3.0458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0356 -2.6333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3212 -3.0458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6067 -2.6333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6067 -1.8083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3212 -1.3958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0356 -1.8083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3212 -0.5708 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.6067 -0.1583 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8922 -1.3958 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.1777 -1.8083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8922 -3.0458 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.1777 -2.6333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1743 -4.4060 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 2 0
5 6 1 0
1 6 1 0
7 8 1 0
8 9 2 0
6 9 1 0
1 7 2 0
12 13 1 0
10 11 2 0
10 12 1 0
9 10 1 0
14 15 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
15 20 2 0
21 22 1 0
19 21 1 0
23 24 1 0
18 23 1 0
25 26 1 0
17 25 1 0
13 14 2 0
8 27 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 368.39 | Molecular Weight (Monoisotopic): 368.1485 | AlogP: 2.43 | #Rotatable Bonds: 6 |
Polar Surface Area: 86.45 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 8 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 12.79 | CX Basic pKa: 4.32 | CX LogP: 1.33 | CX LogD: 1.33 |
Aromatic Rings: 3 | Heavy Atoms: 27 | QED Weighted: 0.53 | Np Likeness Score: -1.76 |
References
1. Samala G, Nallangi R, Devi PB, Saxena S, Yadav R, Sridevi JP, Yogeeswari P, Sriram D.. (2014) Identification and development of 2-methylimidazo[1,2-a]pyridine-3-carboxamides as Mycobacterium tuberculosis pantothenate synthetase inhibitors., 22 (15): [PMID:24953948] [10.1016/j.bmc.2014.05.038] |